Susquehanna International Group’s CG Oncology CGON Stock Holding History

Susquehanna International Group’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.2M	Buy	650,200 +273,500	+73%	+$17.9M	﹤0.01%	1591
2026 Q1	$25.5M	Buy	376,700 +133,900	+55%	+$7.59M	﹤0.01%	1921
2025 Q4	$10.1M	Buy	242,800 +192,300	+381%	+$7.96M	﹤0.01%	3027
2025 Q3	$2.03M	Sell	50,500 -1,000	-2%	-$29.1K	﹤0.01%	5763
2025 Q2	$1.34M	Buy	51,500 +21,200	+70%	+$511K	﹤0.01%	6709
2025 Q1	$742K	Sell	30,300 -133,100	-81%	-$3.74M	﹤0.01%	8008
2024 Q4	$4.69M	Buy	163,400 +110,300	+208%	+$3.77M	﹤0.01%	3695
2024 Q3	$2M	Buy	+53,100	New	+$1.86M	﹤0.01%	5260

Other funds holding CGON

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Susquehanna International Group's CGON Position: Q2 2026 in Review

Susquehanna International Group reduced its CG Oncology (CGON) stake by 39% in Q2 2026, selling an estimated $663K and leaving 15,653 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #7927.

Susquehanna International Group first reported a position in CGON in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.44M in Q2 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

Susquehanna International Group held 15,653 shares of CG Oncology worth $1.11M as of Q2 2026.
Susquehanna International Group sold 10,150 CG Oncology shares in Q2 2026, an estimated $663K.
CG Oncology made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #7927 holding.
Susquehanna International Group first reported a position in CG Oncology in Q1 2024 and has held it in 7 quarters since.
Susquehanna International Group's CG Oncology position peaked at $2.44M in Q2 2025.
227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.